CPA
GNMK

Cowen Prime Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Cowen Prime Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-174,850
Closed -$4.18M – 175
2021
Q1 		$4.18M Sell
174,850
-332,150
-66% -$6.17M 1.58% 12
2020
Q4 		$7.4M Buy
507,000
+124,900
+33% +$1.66M 3.28% 9
2020
Q3 		$5.43M Buy
+382,100
New +$5.84M 2.64% 8

Cowen Prime Advisors's GNMK Position: Q2 2021 in Review

Cowen Prime Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 174,850 shares — an estimated $4.18M sold.

Cowen Prime Advisors first reported a position in GNMK in Q3 2020 and held it in 3 quarters. The position peaked at $7.4M in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Cowen Prime Advisors reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Cowen Prime Advisors sold 174,850 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $4.18M.
  • Cowen Prime Advisors first reported a position in GenMark Diagnostics, Inc in Q3 2020 and held it in 3 quarters.
  • Cowen Prime Advisors's GenMark Diagnostics, Inc position peaked at $7.4M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Cowen Prime Advisors's 13F filing for Q2 2021, filed 16 Jul 2021.